837P Phase II trial of oncolytic vaccinia virus primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588)

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 31; p. S628
Main Authors	Holloway, R.W., Mendivil, A.A., Kendrick, J.E., Abaid, L.N., Brown, J.V., Fitzsimmons, C.K., Kennard, J.A., King, M., LeBlanc, J., Lopez, K., Manyam, M., McKenzie, N.D., Mori, K.M., Stephens, A.J., Ahmad, S.
Format	Journal Article
Language	English
Published	Elsevier Ltd 01.09.2020
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534 1569-8041
DOI:	10.1016/j.annonc.2020.08.976